Catheter ablation of atrial fibrillation in patients with concomitant left ventricular impairment: A systematic review of efficacy and effect on ejection fraction

Heart Lung and Circulation

Volumn 24, Issue 3, 2015, Pages 270-280

  Ganesan, Anand N ^a   Nandal, Savvy ^a   Lüker, Jakob ^a   Pathak, Rajeev K ^a   Mahajan, Rajiv ^a   Twomey, Darragh ^a   Lau, Dennis H ^a   Sanders, Prashanthan ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Atrial fibrillation; Catheter ablation; Heart failure; Rhythm control; Systematic review

Indexed keywords

ARTICLE; CATHETER ABLATION; CLINICAL EFFECTIVENESS; DISEASE ASSOCIATION; EXERCISE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; META ANALYSIS (TOPIC); PATIENT SAFETY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT OUTCOME; ADVERSE EFFECTS; ATRIAL FIBRILLATION; HEART STROKE VOLUME; HEART VENTRICLE; MEDLINE; PATHOPHYSIOLOGY; PROCEDURES;

ATRIAL FIBRILLATION; CATHETER ABLATION; HEART VENTRICLES; HUMANS; PUBMED; STROKE VOLUME;

EID: 84923276339     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2014.09.012     Document Type: Article

References (37)

1. Anter E., Jessup M., Callans D.J. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation. 2009, 119(18):2516-2525.
2. Wang T.J., Larson M.G., Levy D., Vasan R.S., Leip E.P., Wolf P.A., et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003, 107(23):2920-2925.
3. Wasywich C.A., Pope A.J., Somaratne J., Poppe K.K., Whalley G.A., Doughty R.N. Atrial fibrillation and the risk of death in patients with heart failure: a literature-based meta-analysis. Internal Medicine Journal. 2010, 40(5):347-356.
4. Calkins H., Kuck K.H., Cappato R., Brugada J., Camm A.J., Chen S.A., et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2012, 9(4):632-696. e21.
5. Camm A.J., Kirchhof P., Lip G.Y., Schotten U., Savelieva I., Ernst S., et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010, 31(19):2369-2429.
6. Higgins J, Green, S. Cochrane Handbook for Systematic Reviews of Interventions 2009. Available from: http://www.cochrane-handbook.org/. http://www.cochrane-handbook.org/.
7. Anselmino M., Grossi S., Scaglione M., Castagno D., Bianchi F., Senatore G., et al. Long-term results of transcatheter atrial fibrillation ablation in patients with impaired left ventricular systolic function. Journal of Cardiovascular Electrophysiology. 2013, 24(1):24-32.
8. Bortone A., Boveda S., Pasquie J.-L., Pujadas-Berthault P., Marijon E., Appetiti A., et al. Sinus rhythm restoration by catheter ablation in patients with long-lasting atrial fibrillation and congestive heart failure: impact of the left ventricular ejection fraction improvement on the implantable cardioverter defibrillator insertion indication. Europace. 2009, 11(8):1018-1023.
9. Bortone A., Pujadas-Berthault P., Karam N., Maupas E., Boulenc J.M., Rioux P., et al. Catheter ablation in selected patients with depressed left ventricular ejection fraction and persistent atrial fibrillation unresponsive to current cardioversion. Europace. 2013.
10. Chen M.S., Marrouche N.F., Khaykin Y., Gillinov A.M., Wazni O., Martin D.O., et al. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coll Cardiol. 2004, 43(6):1004-1009.
11. De Potter T., Berruezo A., Mont L., Matiello M., Tamborero D., Santibanez C., et al. Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation. Europace. 2010, 12(1):24-29.
12. Efremidis M., Sideris A., Xydonas S., Letsas K.P., Alexanian I.P., Manolatos D., et al. Ablation of atrial fibrillation in patients with heart failure: reversal of atrial and ventricular remodelling. Hellenic J Cardiol. 2008, 49(1):19-25.
13. Gentlesk P.J., Sauer W.H., Gerstenfeld E.P., Lin D., Dixit S., Zado E., et al. Reversal of left ventricular dysfunction following ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2007, 18(1):9-14.
14. Hsu L.F., Jais P., Sanders P., Garrigue S., Hocini M., Sacher F., et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med. 2004, 351(23):2373-2383.
15. Kucukdurmaz Z., Kato R., Erdem A., Golcuk E., Tobiume T., Nagase T., et al. Catheter ablation for atrial fibrillation results in greater improvement in cardiac function in patients with low versus normal left ventricular ejection fraction. J Interv Card Electrophysiol. 2013, 37(2):179-187.
16. Lutomsky B.A., Rostock T., Koops A., Steven D., Mullerleile K., Servatius H., et al. Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging. Europace. 2008, 10(5):593-599.
17. Nademanee K., Schwab M.C., Kosar E.M., Karwecki M., Moran M.D., Visessook N., et al. Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation. J Am Coll Cardiol. 2008, 51(8):843-849.
18. Nedios S., Sommer P., Dagres N., Kosiuk J., Arya A., Richter S., et al. Long-term follow-up after atrial fibrillation ablation in patients with impaired left ventricular systolic function. The importance of rhythm and rate control. Heart Rhythm. 2013.
19. Takahashi Y., Takahashi A., Kuwahara T., Okubo K., Takagi K., Watari Y., et al. Outcomes after stepwise ablation for persistent atrial fibrillation in patients with heart failure. Journal of Arrhythmia. 2012, 28(6):347-352.
20. Tondo C., Mantica M., Russo G., Avella A., De Luca L., Pappalardo A., et al. Pulmonary vein vestibule ablation for the control of atrial fibrillation in patients with impaired left ventricular function. Pacing Clin Electrophysiol. 2006, 29(9):962-970.
21. MacDonald M.R., Connelly D.T., Hawkins N.M., Steedman T., Payne J., Shaw M., et al. Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: A randomised controlled trial. Heart. 2011, 97(9):740-747.
22. Khan M.N., Jais P., Cummings J., Di Biase L., Sanders P., Martin D.O., et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med. 2008, 359(17):1778-1785.
23. Jones D.G., Haldar S.K., Hussain W., Sharma R., Francis D.P., Rahman-Haley S.L., et al. A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. Journal of the American College of Cardiology. 2013, 61(18):1894-1903.
24. Hunter R.J., Berriman T.J., Diab I., Kamdar R., Richmond L., Baker V., et al. A Randomised Controlled Trial of Catheter Ablation versus Medical Treatment of Atrial Fibrillation in Heart Failure (THE CAMTAF TRIAL). Circulation Arrhythmia and Electrophysiology. 2014.
25. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002, 21(11):1539-1558.
26. Jones D.G., Haldar S.K., Jarman J.W., Johar S., Hussain W., Markides V., et al. Impact of stepwise ablation on the biatrial substrate in patients with persistent atrial fibrillation and heart failure. Circ Arrhythm Electrophysiol. 2013, 6(4):761-768.
27. Choi A.D., Hematpour K., Kukin M., Mittal S., Steinberg J.S. Ablation vs medical therapy in the setting of symptomatic atrial fibrillation and left ventricular dysfunction. Congestive Heart Fail. 2010, 16(1):10-14.
28. Reant P., Lafitte S., Jais P., Serri K., Weerasooriya R., Hocini M., et al. Reverse remodeling of the left cardiac chambers after catheter ablation after 1 year in a series of patients with isolated atrial fibrillation. Circulation. 2005, 112(19):2896-2903.
29. Medi C., Kalman J.M., Haqqani H., Vohra J.K., Morton J.B., Sparks P.B., et al. Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation. J Am Coll Cardiol. 2009, 53(19):1791-1797.
30. Gupta A., Perera T., Ganesan A., Sullivan T., Lau D.H., Roberts-Thomson K.C., et al. Complications of catheter ablation of atrial fibrillation: a systematic review. Circ Arrhythm Electrophysiol. 2013, 6(6):1082-1088.
31. Wilton S.B., Fundytus A., Ghali W.A., Veenhuyzen G.D., Quinn F.R., Mitchell L.B., et al. Meta-analysis of the effectiveness and safety of catheter ablation of atrial fibrillation in patients with versus without left ventricular systolic dysfunction. Am J Cardiol 2010, 106(9):1284-1291.
32. Everett TH, Wilson E.E., Hulley G.S., Olgin J.E. Transmural characteristics of atrial fibrillation in canine models of structural and electrical atrial remodeling assessed by simultaneous epicardial and endocardial mapping. Heart Rhythm 2010, 7(4):506-517.
33. Lau D.H., Psaltis P.J., Mackenzie L., Kelly D.J., Carbone A., Worthington M., et al. Atrial remodeling in an ovine model of anthracycline-induced nonischemic cardiomyopathy: remodeling of the same sort. J Cardiovasc Electrophysiol 2011, 22(2):175-182.
34. Platonov P.G. Substrate for development of atrial fibrillation in patients with congestive heart failure: are we close to the answer?. Heart Rhythm. 2009, 6(4):452-453.
35. Sanders P., Morton J.B., Davidson N.C., Spence S.J., Vohra J.K., Sparks P.B., et al. Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans. Circulation. 2003, 108(12):1461-1468.
36. Talajic M., Khairy P., Levesque S., Connolly S.J., Dorian P., Dubuc M., et al. Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation. J Am Coll Cardiol 2010, 55(17):1796-1802.
37. Marrouche N.F., Brachmann J. Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation (CASTLE-AF) - study design. Pacing Clin Electrophysiol. 2009, 32(8):987-994.